Noncovalent inhibitors reveal BTK gatekeeper and auto-inhibitory residues that control its transforming activity
Shenqiu Wang(Memorial Sloan Kettering Cancer Center), Hans‐Guido Wendel(Kettering University)
Cited by 33
Related Papers
Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma
|The Journal of Experimental Medicine|2011|114
Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy
|The Journal of Experimental Medicine|2014|33
A Rapid Translational Immune Response Program in CD8 Memory T Lymphocytes
|The Journal of Immunology|2022|12